NYSE$AHR
American Healthcare REIT Inc · Q1 2026 earnings
Q1 2026 earnings · · Investor relations
Briefing
American Healthcare REIT reported Q1 2026 total revenues of $650.8M and net income attributable to controlling interest of $23.7M ($0.13 basic EPS).
AHR generated Q1 2026 total revenues of $650.8 million (+20% YoY), split between resident fees ($610M) and real estate revenue ($41M). Net income attributable to controlling interest was $23.7 million versus a $6.8 million loss a year ago; basic EPS was $0.13. Property operating expenses rose with portfolio scale while interest expense was $18.8 million.
- Total revenues $650.8M (+20%); resident fees $609.8M.
- Net income to controlling interest $23.7M vs. $(6.8)M prior year.
- Basic EPS $0.13; NOI drivers include occupancy and rate increases.
- Property operating expenses $512.2M; depreciation $67.1M.
- Senior housing/skilled nursing mix per payor tables in filing.
Headline financials
Revenue & EPS history
American Healthcare REIT Inc · Revenue · Quarterly
$651M
Revenue by segment
American Healthcare REIT Inc · $543M total across 4 segments · Q4 2024
- ISHC$423M—78.0%
- SHOP$73.5M—13.6%
- Outpatient Medical$33.3M—6.1%
- Triple-Net Leased$12.6M—2.3%
Forward guidance
MD&A cites occupancy gains and billing rate increases in Q1; ATM forward-sale programs noted for capital.
Tailwinds
- Return to profitability on revenue scale.
- Occupancy and rate tailwinds in senior housing.
- Real estate and resident fee growth.
Headwinds
- High operating and depreciation load.
- Interest and impairment risk on portfolio.
- REIT cap rate / labor cost pressure industry-wide.
Historical earnings impact
How earnings announcements have historically affected this stock's price.
Avg. return before/after earnings
Based on 11 quarterly earnings reports · overlaid with Q1 2026
+1.8%
Avg return
Earnings day
+2.2%
Avg return
5 days after
+3.9%
Avg return
30 days after
64%
7 / 11 earnings
Positive
+8.3%
Q1 2025
Best reaction
-2.1%
Q4 2025
Worst reaction
| Quarter | Report date | Reaction (Day 0) | +5 days | +30 days |
|---|---|---|---|---|
| Q2 2026 | — | — | — | |
| Q1 2026 | +4.3% | +4.1% | -4.2% | |
| Q4 2025 | -2.1% | -2.5% | -11.4% | |
| Q3 2025 | +3.0% | -0.1% | +4.6% | |
| Q2 2025 | +1.3% | +2.0% | +7.2% | |
| Q1 2025 | +8.3% | +6.1% | +10.2% | |
| Q4 2024 | -1.3% | +0.7% | +0.8% | |
| Q3 2024 | +1.2% | +2.7% | +7.1% | |
| Q2 2024 | +3.3% | +3.6% | +35.1% | |
| Q1 2024 | -0.1% | +3.5% | +6.2% | |
| Q2 2023 | +2.8% | +1.3% | -6.8% | |
| Q4 2023 | -0.8% | +3.2% | -5.9% | |
| Q3 2023 | — | — | — | |
| Q1 2023 | — | — | — | |
| Q4 2022 | — | — | — | |
| Q3 2022 | — | — | — | |
| Q2 2022 | — | — | — | |
| Q1 2022 | — | — | — | |
| Q4 2021 | — | — | — | |
| Q3 2021 | — | — | — | |
| Q2 2021 | — | — | — | |
| Q1 2021 | — | — | — | |
| Q4 2020 | — | — | — | |
| Q3 2020 | — | — | — | |
| Q2 2020 | — | — | — | |
| Q1 2020 | — | — | — | |
| Q4 2019 | — | — | — | |
| Q3 2019 | — | — | — | |
| Q2 2019 | — | — | — | |
| Q1 2019 | — | — | — | |
| Q3 2018 | — | — | — | |
| Q2 2018 | — | — | — | |
| Q1 2018 | — | — | — | |
| Q3 2017 | — | — | — | |
| Q2 2017 | — | — | — | |
| Q1 2017 | — | — | — |
Discussion
Share your read of this quarter. Sign-in carries your eToro identity.
Join the conversation
Sign in with eToro to post your read of this quarter and vote on others'.
Sign in with eToro